全文获取类型
收费全文 | 1516044篇 |
免费 | 115701篇 |
国内免费 | 4936篇 |
专业分类
耳鼻咽喉 | 18815篇 |
儿科学 | 48355篇 |
妇产科学 | 40154篇 |
基础医学 | 221232篇 |
口腔科学 | 40092篇 |
临床医学 | 147497篇 |
内科学 | 296476篇 |
皮肤病学 | 28843篇 |
神经病学 | 129364篇 |
特种医学 | 54276篇 |
外国民族医学 | 380篇 |
外科学 | 212768篇 |
综合类 | 32004篇 |
现状与发展 | 3篇 |
一般理论 | 746篇 |
预防医学 | 131549篇 |
眼科学 | 32849篇 |
药学 | 111341篇 |
7篇 | |
中国医学 | 3475篇 |
肿瘤学 | 86455篇 |
出版年
2021年 | 13883篇 |
2019年 | 14555篇 |
2018年 | 19783篇 |
2017年 | 15082篇 |
2016年 | 16165篇 |
2015年 | 18651篇 |
2014年 | 26040篇 |
2013年 | 39740篇 |
2012年 | 55394篇 |
2011年 | 59151篇 |
2010年 | 34027篇 |
2009年 | 31282篇 |
2008年 | 54264篇 |
2007年 | 57441篇 |
2006年 | 57060篇 |
2005年 | 55906篇 |
2004年 | 53355篇 |
2003年 | 50603篇 |
2002年 | 48911篇 |
2001年 | 62594篇 |
2000年 | 63903篇 |
1999年 | 54145篇 |
1998年 | 17041篇 |
1997年 | 15373篇 |
1996年 | 15057篇 |
1995年 | 14195篇 |
1994年 | 13211篇 |
1993年 | 12387篇 |
1992年 | 42726篇 |
1991年 | 41843篇 |
1990年 | 40461篇 |
1989年 | 38256篇 |
1988年 | 35542篇 |
1987年 | 34665篇 |
1986年 | 33103篇 |
1985年 | 31674篇 |
1984年 | 24365篇 |
1983年 | 20915篇 |
1982年 | 13362篇 |
1981年 | 11744篇 |
1979年 | 21560篇 |
1978年 | 15694篇 |
1977年 | 12913篇 |
1976年 | 12625篇 |
1975年 | 12740篇 |
1974年 | 15431篇 |
1973年 | 15042篇 |
1972年 | 13789篇 |
1971年 | 12766篇 |
1970年 | 11817篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them. 相似文献
102.
103.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study 下载免费PDF全文
104.
105.
Dana Franzen-Klein Mark Jankowski Charlotte L. Roy Hoa Nguyen-Phuc Da Chen Lorin Neuman-Lee 《Journal of toxicology and environmental health. Part A》2020,83(2):45-65
ABSTRACTDomestic chickens (Gallus gallus domesticus) were exposed to imidacloprid by gavage once daily for 7 consecutive days at 0, 0.03, 0.34, 3.42, 10.25, and 15.5 mg/kg/day (n = 20 per group; 5 6-week-old males, 5 6-week-old females, 5 9-week-old males, and 5 9-week-old females). The severity and duration of neurobehavioral abnormalities were recorded. Components of the innate and adaptive immune system were assessed with 7 standard functional assays. Temporary neurobehavioral abnormalities were observed in a dose-dependent manner, including muscle tremors, ataxia, and depressed mentation. Based upon mean clinical severity scores, the no observed adverse effect level (NOAEL) was 3.42 mg/kg/day, and the lowest observed adverse effect level (LOAEL) was 10.25 mg/kg/day. The effective dose value for the presence of any neurobehavioral abnormalities in 50% of the test group (ED50) was 4.62 ± 0.98 mg/kg/day. The ED50 for an adjusted score that included both severity and duration of neurobehavioral abnormalities was 11.24 ± 9.33 mg/kg/day. These ED50 values are equivalent to a 1 kg bird ingesting 29 or 70 imidacloprid treated soybean seeds respectively. Immunotoxicity was not documented, possible causes include the assays were insensitive, relevant immune functions were not examined, or imidacloprid is not immunotoxic at this dosing schedule in this species. Neurobehavioral abnormalities were a more sensitive indicator of the sublethal effects of imidacloprid than immunotoxicity. 相似文献
106.
107.
108.
109.
110.